share_log
Moomoo 24/7 ·  Mar 21 07:14
InflaRx Will Focus Development Activities And Resources Initially On Selected Indications In Immuno-dermatology, With Registrational-phase Vilobelimab And INF904
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment